BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22008156)

  • 1. [Increase in the demand for eye-care services in the Netherlands 2010-2020].
    Keunen JE; Verezen CA; Imhof SM; van Rens GH; Asselbergs MB; Limburg JJ
    Ned Tijdschr Geneeskd; 2011; 155(41):A3461. PubMed ID: 22008156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blindness and low vision in The Netherlands from 2000 to 2020-modeling as a tool for focused intervention.
    Limburg H; Keunen JE
    Ophthalmic Epidemiol; 2009; 16(6):362-9. PubMed ID: 19995201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.
    Xu L; Wang Y; Li Y; Wang Y; Cui T; Li J; Jonas JB
    Ophthalmology; 2006 Jul; 113(7):1134.e1-11. PubMed ID: 16647133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and causes of functional low vision and implications for services: the Pakistan National Blindness and Visual Impairment Survey.
    Shah SP; Minto H; Jadoon MZ; Bourne RR; Dineen B; Gilbert CE; Khan MD;
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):887-93. PubMed ID: 18326708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study.
    Hsu WM; Cheng CY; Liu JH; Tsai SY; Chou P
    Ophthalmology; 2004 Jan; 111(1):62-9. PubMed ID: 14711715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of visual disability in the elderly population of Taiwan.
    Tsai CY; Woung LC; Chou P; Yang CS; Sheu MM; Wu JR; Chuang TL; Tung TH
    Jpn J Ophthalmol; 2005; 49(2):166-72. PubMed ID: 15838737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A telephone survey of low vision services in U.S. schools for the blind and visually impaired.
    Kran BS; Wright DW
    Optometry; 2008 Jul; 79(7):378-90. PubMed ID: 18577495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elderly people with visual impairment in The Netherlands].
    Limburg JJ; Keunen JE; van Rens GH
    Tijdschr Gerontol Geriatr; 2009 Sep; 40(4):149-55. PubMed ID: 20088341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of eye care services and need for assistance in the visually impaired.
    Laitinen A; Koskinen S; Rudanko SL; Martelin T; Laatikainen L; Aromaa A
    Optom Vis Sci; 2008 May; 85(5):341-9. PubMed ID: 18451738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study.
    Gunnlaugsdottir E; Arnarsson A; Jonasson F
    Acta Ophthalmol; 2010 May; 88(3):358-66. PubMed ID: 19222399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study.
    Gunnlaugsdottir E; Arnarsson A; Jonasson F
    Acta Ophthalmol; 2008 Nov; 86(7):778-85. PubMed ID: 18513265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of blindness and visual impairment in a population of people with diabetes.
    Prasad S; Kamath GG; Jones K; Clearkin LG; Phillips RP
    Eye (Lond); 2001 Oct; 15(Pt 5):640-3. PubMed ID: 11702977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and causes of visual impairment in central Sri Lanka the Kandy Eye study.
    Edussuriya K; Sennanayake S; Senaratne T; Marshall D; Sullivan T; Selva D; Casson RJ
    Ophthalmology; 2009 Jan; 116(1):52-6. PubMed ID: 19010549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of visual impairment and blindness in children attending seven schools for the blind in Myanmar.
    Muecke J; Hammerton M; Aung YY; Warrier S; Kong A; Morse A; Holmes M; Yapp M; Hamilton C; Selva D
    Ophthalmic Epidemiol; 2009; 16(6):370-7. PubMed ID: 19995202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey.
    Abdull MM; Sivasubramaniam S; Murthy GV; Gilbert C; Abubakar T; Ezelum C; Rabiu MM;
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4114-20. PubMed ID: 19387071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Social costs of visual handicap and blindness. Rehabilitation resources for blind patients].
    Krumpaszky HG; Klauss V; Kloske G
    Klin Monbl Augenheilkd; 1992 Dec; 201(6):370-4. PubMed ID: 1287358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F; Lafuma A; Berdeaux G
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pakistan national blindness and visual impairment survey--research design, eye examination methodology and results of the pilot study.
    Bourne R; Dineen B; Jadoon Z; Lee PS; Khan A; Johnson GJ; Foster A; Khan D;
    Ophthalmic Epidemiol; 2005 Oct; 12(5):321-33. PubMed ID: 16272052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age related macular degeneration].
    Helgadóttir G; Jónasson F; Sigurdsson H; Magnússon KP; Stefánsson E
    Laeknabladid; 2006 Oct; 92(10):685-96. PubMed ID: 17062902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.